Wednesday, November 16, 2016
12:30 – 2pm
TMEC Walter Amphitheater
Harvard Medical School
260 Longwood Ave
Boston, MA 02115
There has been considerable hype surrounding personalized and precision medicine in the past few years—including President Obama’s 2015 announcement of $215 million for the Precision Medicine Initiative. While some policymakers hail this movement as a pending revolution in healthcare, other commentators are skeptical, arguing that the same funding directed toward the social and behavioral determinants of health would yield far greater gains in terms of patient benefits and healthcare savings.
How important is precision medicine for our healthcare marketplace, and what should the expected outcomes be for public investment in research in this area?
Sandro Galea, MD, MPH, DrPH
Dean and Robert A. Knox Professor
Boston University School of Public Health
Calum A. MacRae, MD, PhD
Chief of Cardiovascular Medicine and Assoc. Prof.
Brigham and Women’s Hospital & Harvard Medical School
Spencer Hey, PhD
Harvard Medical School Center for Bioethics